Evolus (EOLS) Net Margin (2019 - 2026)
Evolus (EOLS) posted Net Margin of -16.06% for Q3 2026, up 6.76 percentage points from -22.82% a year earlier but down 6.48 percentage points from the prior quarter.
Evolus (EOLS) Net Margin (2019 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Net Margin at Evolus was -9.56%, up 10.93 percentage points year-over-year; for FY2025, it was -17.38%, up 1.56 percentage points from FY2024.
- Annual Net Margin has increased for three consecutive years, with a five-year change of +270.94 percentage points (FY2020 to FY2025).
- In prior years, Evolus' Net Margin was -18.94% in FY2024 (+11.59 pp), -30.52% in FY2023 (+19.55 pp), -50.07% in FY2022 (-3.11 pp) and -46.96% in FY2021 (+241.35 pp).
- Quarterly Net Margin has run from a low of -63.16% in Q2 2022 to a high of 0.14% in Q4 2025 over five years.
- On a year-over-year basis, Net Margin has increased in each of the last five quarters, with an average year-over-year change of +6.22 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Net Margin in the past five years was Q4 2021, with a gain of 485.50 percentage points; the weakest was Q1 2022, with a drop of 103.90 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -9.58% (Q2 2026), -14.59% (Q1 2026) and 0.14% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 22.65% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 16.30% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 19.55% |
| 10 | Evolus | 455.33 Mn | 264.84 Mn | 50.69 Mn | -16.06% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -16.06% |
| Jun 30, 2026 | -9.58% |
| Mar 31, 2026 | -14.59% |
| Dec 31, 2025 | 0.14% |
| Sep 30, 2025 | -22.82% |
| Jun 30, 2025 | -24.70% |
| Mar 31, 2025 | -27.57% |
| Dec 31, 2024 | -8.60% |
| Sep 30, 2024 | -31.38% |
| Jun 30, 2024 | -16.96% |
| Mar 31, 2024 | -22.09% |
| Dec 31, 2023 | -19.40% |
| Sep 30, 2023 | -33.83% |
| Jun 30, 2023 | -36.76% |
| Mar 31, 2023 | -35.45% |
| Dec 31, 2022 | -30.16% |
| Sep 30, 2022 | -59.81% |
| Jun 30, 2022 | -63.16% |
| Mar 31, 2022 | -51.61% |
| Dec 31, 2021 | -52.45% |
Evolus Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "EOLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=EOLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();